This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
129 MUTATION IN TET2 OR TP53 PREDICTS POOR SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROME RECEIVING HYPOMETHYLATING TREATMENT OR STEM CELL TRANSPLANTATION. (April 2015)
Record Type:
Journal Article
Title:
129 MUTATION IN TET2 OR TP53 PREDICTS POOR SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROME RECEIVING HYPOMETHYLATING TREATMENT OR STEM CELL TRANSPLANTATION. (April 2015)
Main Title:
129 MUTATION IN TET2 OR TP53 PREDICTS POOR SURVIVAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROME RECEIVING HYPOMETHYLATING TREATMENT OR STEM CELL TRANSPLANTATION